Stereotaxis
Manufacturing · Missouri, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
710 N Tucker Blvd Ste 110, St. Louis, Mi...Phone Number
(314) 678-6100Website
www.stereotaxis.comRevenue
$31.2 MillionStock Symbol
STXSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room.Explore more
Stereotaxis Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stereotaxis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Stereotaxis, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Stereotaxis has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Stereotaxis
Click to see if Stereotaxis had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Stereotaxis has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Stereotaxis recently announced quarterly report
Check out if Stereotaxis is spiking on competitors!
Product Launch: Get notified when Stereotaxis launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Stereotaxis
Compare insights from companies similar to Stereotaxis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Stereotaxis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Stereotaxis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Stereotaxis.
Stereotaxis financials insights
Gather financial insights about Stereotaxis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$10.2M
2014
Debt
$10M
2016
Share Placement
$24M
2018
Other Financing Round
$10M
2019
Share Placement
$25M
2020
Debt
$2M
Share Placement
$15M
2025
Other Financing Round
$50M
Stereotaxis Tech Stack
A closer look at the technologies used by Stereotaxis
See more technologies
Most Recent Scoops
Person-Based
Product Launch
Person-Based
Product Development, Product Launch
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Stereotaxis News & Media
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
ST. LOUIS, May 12, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the first quarter ended March 31, 2026.Stereotaxis Announces First MAGiC Procedures in the United States
ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated using MAGiC™.Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026
ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 first quarter on Tuesday, May 12, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company’s results and corporate developments.Stereotaxis, Inc. (STXS) M&A Call Transcript
Stereotaxis, Inc. (STXS) M&A Call April 15, 2026 9:00 AM EDTCompany ParticipantsDavid Fischel - CEO & ChairmanPhilippe BencteuxConference Call...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stereotaxis
Sign Up For FreeTo access detailed company insights
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient c... Read More
